P3 Study Brodalumab in Treatment of Moderate to Severe Plaque Psoriasis
Part of paid clinical trials in Birmingham, Alabama.
- Sponsor
- Bausch Health Americas, Inc.
- Study ID
- NCT01708603
- Phase
- PHASE3
- Status
- Terminated
Conditions
- Moderate to Severe Plaque Psoriasis
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - 75 Years
- Healthy Volunteers
- Not accepted
Interventions
- 210 mg brodalumab — DRUG210 mg brodalumab administered SC
- 140 mg brodalumab — DRUG140 mg brodalumab administered SC
- ustekinumab — DRUG45 mg or 90 mg ustekinumab administered SC per the labeled dosing regimen.
- placebo — DRUGPlacebo administered SC
Study Details
The purpose of this study is to assess the safety and efficacy of brodalumab at two different doses
Key Dates
- Start date
- Aug 31, 2012
- Status verified
- Jan 2020
- Primary completion
- Sep 30, 2014
- Completion
- Oct 31, 2015
Study Design
- Enrollment
- 1,831 participants (actual)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Experimental: 210 mg brodalumabAdministered by subcutaneous (SC) injection until week 12. At week 12, participants are rerandomized to schedule 1, 2, 3, or 4.
- Experimental: 140 mg brodalumabAdministered by subcutaneous (SC) injection until week 12. At week 12, participants are rerandomized to schedule 1, 2, 3, or 4.
- Active Comparator: ustekinumabAdministered by subcutaneous (SC) injection per the labeled dosing regimen.
- Placebo Comparator: PlaceboAdministered by subcutaneous (SC) injection until week 12. At week 12 participants are assigned to 210 mg brodalumab.
Primary Outcome Measure
Percentage of Participants With Static Physician Global Assessment (sPGA) Score Success (Score of 0 or 1) at Week 12 [ Time Frame: 12 weeks ]
Locations (67)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Research Site | Birmingham | Alabama | 35233 | - |
| Research Site | Tucson | Arizona | 85710 | - |
| Research Site | Hot Springs | Arkansas | 71913 | - |
| Research Site | Bakersfield | California | 93309 | - |
| Research Site | Beverly Hills | California | 90211 | - |
| Research Site | Irvine | California | 92697 | - |
| Research Site | Los Angeles | California | 90027 | - |
| Research Site | Los Angeles | California | 90045 | - |
| Research Site | Sacramento | California | 95816 | - |
| Research Site | San Diego | California | 92103 | - |
| Research Site | San Diego | California | 92123 | - |
| Research Site | Vista | California | 92083 | - |
| Research Site | Denver | Colorado | 80209 | - |
| Research Site | Denver | Colorado | 80210 | - |
| Research Site | Denver | Colorado | 80239 | - |
| Research Site | New Haven | Connecticut | 06511 | - |
| Research Site | Aventura | Florida | 33180 | - |
| Research Site | Jacksonville | Florida | 32216 | - |
| Research Site | Miami | Florida | 33136 | - |
| Research Site | Pembroke Pines | Florida | 33028 | - |
| Research Site | Tampa | Florida | 33612 | - |
| Research Site | Atlanta | Georgia | 30342 | - |
| Research Site | Newnan | Georgia | 30263 | - |
| Research Site | Snellville | Georgia | 30078 | - |
| Research Site | Chicago | Illinois | 60611 | - |
| Research Site | Chicago | Illinois | 60654 | - |
| Research Site | Skokie | Illinois | 60077 | - |
| Research Site | Carmel | Indiana | 46032 | - |
| Research Site | Plainfield | Indiana | 46168 | - |
| Research Site | South Bend | Indiana | 46617 | - |
| Research Site | Louisville | Kentucky | 40202 | - |
| Research Site | Lake Charles | Louisiana | 70601 | - |
| Research Site | Lake Charles | Louisiana | 70605 | - |
| Research Site | New Orleans | Louisiana | 70112 | - |
| Research Site | Rockville | Maryland | 20850 | - |
| Research Site | Silver Spring | Maryland | 20902 | - |
| Research Site | Boston | Massachusetts | 02114 | - |
| Research Site | Boston | Massachusetts | 02115 | - |
| Research Site | North Andover | Massachusetts | 01845 | - |
| Research Site | Ann Arbor | Michigan | 48109 | - |
| Research Site | Fridley | Minnesota | 55432 | - |
| Research Site | Omaha | Nebraska | 68144 | - |
| Research Site | Henderson | Nevada | 89074 | - |
| Research Site | Brooklyn | New York | 11209 | - |
| Research Site | New York | New York | 10029 | - |
| Research Site | Rochester | New York | 14625 | - |
| Research Site | Charlotte | North Carolina | 28210 | - |
| Research Site | Durham | North Carolina | 27710 | - |
| Research Site | Raleigh | North Carolina | 27612 | - |
| Research Site | Winston-Salem | North Carolina | 27103 | - |
| Research Site | Beachwood | Ohio | 44122 | - |
| Research Site | Columbus | Ohio | 43212 | - |
| Research Site | Gahanna | Ohio | 43230 | - |
| Research Site | South Euclid | Ohio | 44118 | - |
| Research Site | Portland | Oregon | 97239 | - |
| Research Site | Pittsburgh | Pennsylvania | 15213 | - |
| Research Site | Anderson | South Carolina | 29621 | - |
| Research Site | Mt. Pleasant | South Carolina | 29464 | - |
| Research Site | Austin | Texas | 78759 | - |
| Research Site | Dallas | Texas | 75246 | - |
| Research Site | Houston | Texas | 77065 | - |
| Research Site | San Antonio | Texas | 78229 | - |
| Research Site | San Antonio | Texas | 78249 | - |
| Research Site | West Jordan | Utah | 84088 | - |
| Research Site | Norfolk | Virginia | 23502 | - |
| Research Site | Roanoke | Virginia | 24016 | - |
| Research Site | Seattle | Washington | 98101 | - |
Find similar trials in Birmingham, AL
Related Studies
- A Study to Evaluate the Efficacy and Safety of Bimekizumab Compared to Ustekinumab in Children and Adolescents From 6 Years to Less Than 18 Years of Age With Moderate to Severe Plaque PsoriasisPHASE3 · Recruiting · UCB Biopharma SRL · Fountain Valley, California
- A Study to Assess the Concentration of Bimekizumab in Mature Breast Milk From Mothers Receiving Treatment With Bimzelx® (Bimekizumab)PHASE1 · Recruiting · UCB Biopharma SRL · Santa Monica, California